Paula Amat

Universitat de València — Spain

Medicine · Health Sciences

21h-index1.2kcitations91works3.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cytomegalovirus and herpesvirus research(35), Herpesvirus Infections and Treatments(17), CAR-T cell therapy research(13), Hematopoietic Stem Cell Transplantation(12), Immune Cell Function and Interaction(12)

Publications90 total

Patterns of immune recovery after axicabtagene ciloleucel for aggressive B‐cell lymphoma
HemaSphere·2025Open Access
TLR7/8 ligands R848 and imiquimod induce differentiation of bone marrow cells from patients with myelodysplastic syndrome towards mature neutrophils
Scientific Reports·2025· 1 citedOpen Access
Frequency and Distribution of <i>KIR</i> Genotypes of Donors‐Recipient Pairs in the Haploidentical Haematopoietic Stem Cell Transplantation Setting: Collaborative Study by the Spanish Working Group in Histocompatibility and Transplant Immunology (GETHIT) and the Spanish Haematopoietic Transplantation and Cell Therapy Group (GETH‐TC)
HLA·2025· 1 cited
Clinical Impact of CD19 Expression Assessed by Quantitative PCR in Lymphoma Patients Undergoing CAR‐T Therapy
eJHaem·2025· 1 citedOpen Access
The landscape of immune monitoring in CAR-T cell therapy: A comprehensive review and survey study by the Cellular Therapy and Immunobiology Working Party of the EBMT
Blood Reviews·2025· 3 citedOpen Access
P-110 - UTILIDAD DEL LINFOGRAMA INTRAEPITELIAL COMO HERRAMIENTA COMPLEMENTARIA EN EL DIAGNÓSTICO DE ENFERMEDAD CELIACA EN EL ADULTO EN UN HOSPITAL TERCIARIO
Gastroenterología y Hepatología·2025
Efficacy and safety of bendamustine‐containing bridging therapy in R/R LBCL patients receiving CD19 CAR T‐cells
HemaSphere·2024· 7 citedOpen Access
Incidence and clinical correlates of <i>NFE2</i> mutations in myeloid neoplasms
British Journal of Haematology·2024
EEG before chimeric antigen receptor T-cell therapy and early after onset of immune effector cell-associated neurotoxicity syndrome
Clinical Neurophysiology·2024· 19 citedOpen Access
e14a2 Transcript Favors Treatment-Free Remission in Chronic Myeloid Leukemia When Associated with Longer Treatment with Tyrosine Kinase Inhibitors and Sustained Deep Molecular Response
Journal of Clinical Medicine·2024· 4 citedOpen Access
Torque Teno Virus plasma DNA load: a novel prognostic biomarker in CAR-T therapy
Bone Marrow Transplantation·2023· 7 citedOpen Access
Recent Bendamustine Treatment Before Apheresis Has a Negative Impact on Outcomes in Patients With Large B-Cell Lymphoma Receiving Chimeric Antigen Receptor T-Cell Therapy
Journal of Clinical Oncology·2023· 109 citedOpen Access
PB2314: CYTOPENIAS AND BLOOD TRANSFUSION SUPPORT AFTER CAR-T THERAPY
HemaSphere·2023· 2 citedOpen Access
PB1962: INFLUENCE OF TRANSCRIPT TYPES IN SUSTAINED DEEP MOLECULAR RESPONSE (SDMR) AND TREATMENT-FREE REMISSION (TFR) IN CHRONIC PHASE-CHRONIC MYELOID LEUKEMIA (CP-CML) PATIENTS TREATED WITH TKI
HemaSphere·2023Open Access
P1151: BENDAMUSTINE-CONTAINING REGIMENS CAN BE SAFELY USED AS BRIDGING IN LARGE B-CELL LYMPHOMA PATIENTS RECEIVING CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY
HemaSphere·2023· 2 citedOpen Access
Assessment of the potential value of plasma Torque Teno virus DNA load monitoring to predict cytomegalovirus DNAemia in patients with hematological malignancies treated with small molecule inhibitors: A proof‐of‐concept study
Journal of Medical Virology·2023· 3 citedOpen Access
Torque Teno Virus Plasma DNA Load: A Novel Prognostic Biomarker in CAR-T Therapy
Research Square (Research Square)·2023· 1 citedOpen Access
Assessment of the potential value of plasma Torque Teno virus DNA load monitoring to predict Cytomegalovirus DNAemia in patients with hematological malignancies treated with small molecule inhibitors: A proof-of-concept study
2023Open Access
Impact of cytomegalovirus immunodominant HLA‐I donor–recipient matching on the incidence and features of virus DNAemia and virus‐specific T‐cell immune reconstitution in unmanipulated haploidentical hematopoietic stem cell transplantation
Transplant Infectious Disease·2023
Features of cytomegalovirus DNAemia and virus‐specific T‐cell responses in allogeneic hematopoietic stem‐cell transplant recipients during prophylaxis with letermovir
Transplant Infectious Disease·2023· 16 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

David Navarro(35), Carlos Solano(33), Estela Giménez(29), Juan Carlos Hernández‐Boluda(18), María José Remigia(17), Beatriz Muñoz‐Cobo(12), Eliseo Albert(12), José Luís Piñana(11), Rafael de la Cámara(8), José Nieto(8), Rafael Hernani(7), Ignacio Torres(7), Ariadna Pérez(7), Beatriz Olea(6), Ana García‐Noblejas(6), Ana Benzaquén(5), Alberto Álvarez‐Larrán(5), Blanca Navarro(5), María Ángeles Clari(5), Isabel Benet(5)